If you have a high risk HR+, BRCA+ breast cancer patient who qualifies for adjuvant olaparib and abemaciclib, which one would you give and why?  

Would you ever consider using these in sequence?



Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Lynn Reg Cancer Center
Thank you.
Medical Oncologist at Breastlink Medical Group
Yes, agreed, interestingly Rb gene sits next to BR...
Medical Oncologist at Florida Cancer Specialists and Research Institute
Thank you very much Dr. @Bora Lim for posting...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution